Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I want to believe......but I have a problem.
I love the people they have on the side of satellite technology.
Here are my issues:
1) R&D and rocket assembly in Alameda, Ca - that is fine but the launch site is in Koaiak, Alaska. I understand the logic - you can send a barge with your rockets up there fairly cheap but that is a horribly inhospitable environment to work in. Closer to the equator would be better.
2) From what I understand Astra has never made it to orbit. They tried last year and failed.
3) There is a thing they call cubes. Cubes are exactly that and they measure 10cm on each side. Tiny satellites. It is sort of a beginners package for rocket people. They have a contract from USA to deliver 6 of them.
So we have a company that has not even made it to orbit yet.
The question you have to ask is will they survive.
Add to that the fact that Rocket Labs is sucking all the cash up. They have launch sites in Delaware and New Zealand. They have a proven track record, have retrieved boosters and are scaling up.
What is the bull case for Astra and its SPAC HOL?
Were they able to catch the booster in the last launch?
Things I worry about:
New Zealand is a hell of a long ways away to drag all your rocket gear.
The other site is in the USA in Delaware which is good.
There is a god-awful lot of money starting up a rocket business.
Are you convinced they can make a profit?
I know the warrants are active 30 days after conversion but what was the outer limit for expiration of the warrants in the S!?
That is because the warrants were way underpriced in relation to the common stock. they have to make up the difference before closing. Voting day is next week for the closure.
And then there are the people who spend their valuable time going around to boards telling investors how stupid they are and how their stock is going to zero.
You are either a short seller or someone who wastes their valuable time telling everyone what a loser they are.
Do you know the results of the inhaler study? What is it?
Some other things not discussed:
1) Tillman is calling in the Warrants now that they are public. Hence we have dilution.
2) Just after a company finally becomes public you have all kinds of insider options that can, and will, be sold.
3) FST is a SPAC taking Tillman's hotels public causing some people to think twice.
Hopefully all this is transitory and the numbers speak for themselves. We make money.
Why the big selloff??
I guess everybody expected miracles?
The report was not that bad.
Hi Guys,
This is for the SPAC called PIPP
Tony Blinken - Biden’s choice to be secretary of State
Gen. Lloyd Austin - Nominated to be secretary of Defense worked with Raytheon, aerospace --> F35 helmet development
Philip A. Cooper – Goldman Sachs Chief Investment Officer
John A. Thain - Chief Executive Officer. New York Stock Exchange & Goldman Sachs President
Stuart W. Holliday - U.S. Ambassador for Special Political Affairs at the United Nations
Michael E. Roemer - Chief auditor at CIT Group Inc.
https://www.cnbc.com/2020/12/09/spac-with-ties-to-biden-cabinet-picks-sees-surge-in-wall-street-support.html
Sounds like a pretty impressive board.
What do you think?
You are right.
He just wanted to know the % the SPAC got.
5% sounds about right.
I have a question that's been bothering me:
Obviously the value of BItCoin is its use as a currency.
It is not a "store of value" and everybody knows it.
They don't call it BitCOIN and CryptoCURRENCY for nothing.
The desire is to have BitCoin replace the dollar.
Isn't that really dangerous?
If BitCoin replaces the dollar, then we no longer have control our own currency.
How can our government respond to a sudden crisis where massive amounts or money are needed immediately?
For example, a horrible set of hurricanes or even a war where we have to defend ourselves?
If BitCoin is the currency we cannot print BitCoin so we cannot respond to disasters.
That sounds like a disaster to me. Please explain.
Powerwalker,
Perhaps you can expand on that.
RLFTF is a OTC stock for a Swiss company called Relief Therapeutics.
RLFTF has a profit sharing agreement with NeuroRX where the profits are split 50-50 for the area NeuroRx is allowed to sell in (which is considerable).
BRPA is a SPAC taking NeuroRX public with a final stock symbol NRXP
So how does BRPA (eventually to be NRXP) own 95% of RLFTF stock?
Is this documented in the latest S4?
one to one.
All you are doing is changing the name of the company and the stock ticker.
1) They would not do the inhaler study if the IV study was bad. So it must be good.
2) They are not wasting any time going directly to the inhaler. Starts now.
3) They confirm that the target end result is a "in home" inhaler to be used when disease starts.
Now the question is, does "expected next week" mean "it will happen next week".
That explains a lot of the action.
Big short volume.
GNOG is profitable, unlike a lot of other gaming stocks.
They have a lot going for them with casino betting as well as sports betting.
They have good name recognition.
But they have absolutely no PR.
DKNG is much worse financially, but they have a colorful, energetic, spokesperson on every TV show.
Who does Tillman have? He needs to wake up and smell the coffee.
This is a major test for Tillman and his first exposure to the public markets.
If he cannot get off his ass and promote GNOG then nobody will want to invest in him.
WSJ and IBD have articles on gaming stocks and GNOG is not even mentioned.
IMHO, what is happening kind of makes sense.
The SPAC makers want investors.
There are no option chains because there is not a huge universe of investors.
So the SPAC owners write their own calls called Warrants.
Note that the SPAC owners are the ones that set the price of the Warrants - not the market.
As the stock price goes up the SPAC owners do not want to raise the price of the Warrants because it scares away buyers so they let the gap widen. Note also that if the deal fails the warrants are worthless which is another reason they keep warrant prices low.
However, as we approach the conversion day the warrants have to catch up to the real value which is the difference between the list price and $11.50.
So if you feel real sure we will convert the Warrants are a great deal.
Of course different SPAC owners treat the price of the Warrants differently. Chamath likes to keep his Warrants c lose to the real value.
Crazy world. Note also that once we convert NRXP will probably change the strike day and you have to be ready for that or your warrant will expire worthless.
Perhaps you can find that in the S4?
https://www.sec.gov/Archives/edgar/data/1719406/000119312521019278/d56937ds4.htm#rom56937_3
BRPA is what is called a SPAC stock (Special Purpose Accusation Company).
BRPA bought NeuroRx in a deal where NeuroRx will own almost all the shares.
The SEC needs to approve the deal.
When the deal is officially done, NeuroRx owns the company and immediately changes the ticker to NXRP,
So nothing happens at all to your stock. It simply changes from BRPA to NXRP.
If you had Units, Rights or Warrants then you follow the S1 terms.
My understanding is that NeuroRX has an agreement with RLFTF and they get 50% of profits of RLF-100 for most transactions.
NeuroRX is going public through a SPAC called BRPA which has gone from $24 on Jan 1st to $60 today.
On the downside, the conversion of the SPAC called BRPA to its final NASDAQ status as NRXP takes a while. Maybe March or April. I hope politics and money does not slow down the flow of information about the drug.
So the bottom line is that there is a lot of activity with RLFTF but most of it appears to be with BRPA (NeuroRX) who has rights to sell RLF-100 on a profit sharing basis. There is a big Redit channel on BRPA too. Both RLFTF and BRPA will profit off the drug.
I just wish they would announce the results publicly so we can all get started. I hate the constant waiting and it is almost like teasing......but I know it has to be done correctly.
As I understand it:
BRPAW = Warrants which move over to NRXP when the conversion is done. The strike day is in December of 2022 but NRXP has the right to change that to something much closer to us. You have to convert before the strike day or your warrant is worthless. Agreed that since the warrant is 1:1 conversion it will need to be at or above the list price of NRXP.
BRPAR = Rights and it is 1:10 so you have to buy them in bundles of 10. They convert to the NRXP stock automatically on the conversion day.
I thought the way things were going was this:
1) RLFTF is a small Swiss company so they made a deal with NeuroRX where NeuroRX takes the drug to market and arranges distribution for which NeuroRX (NRXP after the conversion) gets 50% of the profits.
2) This leaves RLFTF as a OTC stock and they may do a reverse split to get itself out of the OTC.
Hows does ACER fit into the picture?
NeuroRX is doing most of the work, right?
Why are people so excited about the UCI study?
It clearly states:
Estimated Study Start Date : January 10, 2021
Estimated Primary Completion Date : July 1, 2021
Estimated Study Completion Date : September 1, 2021
That will take forever.
https://clinicaltrials.gov/ct2/show/NCT04360096
Yes it is a big price performance difference between BRPA and RLFTF but so is the danger.
If BRPA cannot close the deal with RLFTF soon, BRPA goes from $63 to $10 in a heartbeat.
Warrants are indeed at a outrageous discount. Hard to understand that except warrants are not executable until merger date. So you can buy and sell a warrant but you cannot convert them to stock (execute the warrant) until merger date.
Think of it this way:
1) You by a warrant. for $4.50
2) You can sell it now but you only get $4.50.
3) Suppose merger date comes and we are at today's prices.
4) Now you can demand to convert your warrant to stock by paying $11.50 or
5) You can sell your warrant for $20.50 - $11.50 = $9.00 each
Therefore the warrant price has to close the gap from $4.50 to $9.00 sometime before merger date. On the other hand, if the stock price drops before merger date it may only be worth $4.50
Incidentally, this is not uncommon. Look at ACTC and you will see the same thing. The company does not need to worry about creating stock to cover the warrants until we get to conversion day. Them they have to face the music. With real options you have to keep it close all the time because they can be executed anytime.
"Looks like RLF is going to the Nasdaq in the ACER shell"
How does this work? Is ACER merging with RLFTF?
If so please post a link.
Is any of this real or are we just going crazy with speculation?
At $4 /share ACER is not in danger of delisting. Going below $1 is where they kick you out. Even then you can fight it by doing reverse splits. However, ACER has horrible losses for the last few years.
"...the key terms of which are set forth in the Option Agreement, if a definitive agreement is executed pursuant to these terms and closed by June 30, 2021, Acer will receive $15 million in cash (net $10 million, inclusive of the $1 million payment and offset by a repayment of the $4 million loan from Relief). In addition, Relief will agree to pay up to $20 million in U.S. development and commercial launch costs for the UCDs and MSUD indications. Further, Acer will retain development and commercialization rights in the U.S., Canada, Brazil, Turkey and Japan. The companies will split net profits from Acer’s territories 60:40 in favor of Relief. Relief will also license the rights for the rest of the world, where Acer will receive from Relief a 15% net sales royalty on all revenues received in Relief’s territories. Acer could also receive a total of $6 million in milestones based on the first European (EU) marketing approvals for UCDs and MSUD. There can be no assurance, however, that a definitive agreement will be successfully negotiated and executed between the parties on these terms, on other mutually acceptable terms, or at all.... "
That sure does make it sound like a merger if they come to agreement. The dollar payment to ACER is huge and there has to be equal value going to RLFTF - so what is it? The big issue, not discussed, is who owns the resulting ACER company. If the split is 60/40, then does RLFTF own 60% of ACER? All this agreement says is that they are in "talks" to decide if they can find an agreement.....meantime the clock is ticking and people are dying. In defense of RLFTF, they probably have offers from big Pharma for pennies on the dollar and they are trying to find a way to control the business as it rolls out.
Merger? That is exactly what I thought. I wonder if getting bed with ACER is the way to go. There are a zillion genomic SPAC companies out there that would love to take us public for 10%. Getting in bed with ACER means we have fo take on all their debt and dead weight employees. RLFTF should call up someone like Ark-Invest and ask for advice. Or call chamath palihapitiya, king of the SPACs, his company Social Capital would probably love to talk to RLFTF. I wonder who is giving RLFTF advice?
Could somebody please list in bullet form the major financial points and benefits of this agreement?
It all sounds very fuzzy. RLFTF pays a non refundable $1M just to do the deal with ACER and RLFTF also puts up a $4M loan to ACER. ACER is a $4 stock on nasdaq. So we are now $5M in the hole to ACER who has 22 employees and lost $28 Million last year. Naturally, ACER stock is up because they just got a lot of cash. Why not deal with a larger company? The only way I see this making sense is if RLFTF is taking over ACER.
I am the first to admit I do not understand all the details. Could somebody please explain in simple bullet form how RLFTF does well with this deal and what it gives us?
Is RIDE owned by GM?
Is RIDE going to be GMs EV truck division or are they going to do everything in house?
Looking at the trades, RLFTF closed yesterday around $0.50
It opened today at $0.370
So there was a heavy sell off on the Swiss exchange where they are listed.
I would also like to see links to whatever negative articles are out there in the last 2 days.
Searching around, I cannot see any major news item that would cause the sell off.
It looks like Global Emerging Markets North America Made a monster sell so maybe it was just profit taking.
If anybody has seen important news from the last 24 hours, could you post a link?
They have been saying that for years and years. Yes, there are some promising experiments. However, converting that to a functioning reactor is a real problem. Containment is the issue. Don't bet on it anytime soon.
It is all about ARK invest coming back in.
When is this SPAC going to end and we get MP?
It seem like it is going on forever.
150,000 patients a month is insignificant.
I hope one of the big drug companies takes over and really ramps this thing up.
Seems to me all we need are some large, serious results and, hopefully, that includes inhalers.
IMHO, All the weak hands are selling today and tomorrow because they feel the news feed has dried up and they are basically day traders.
Today was a very good news day and pretty much what we expected:
1) With 3 new factories under construction (Shanghai, Berlin and Texas) Tesla knows it has huge battery demands coming and they have known this for years.
2) So they decided to take batteries seriously, completely redesign them from the ground up and make their own battery factories. They bought Maxwell for their talent in this process.
3) Today they announced that they have pretty much finished the prototype of their new battery and they know it works. There is still some tweaking to do but it works.
4) This new battery affects the entire construction of the car itself in a good way.
5) They will continue to get batteries from their existing suppliers and by the time that Berlin and Texas are up and running their new battery factories will be up and running.
6) Berlin will have a battery factory as well as Texas.
7) The Plaid Model S is taking orders and it is faster and more milage than any other car in production.
8) Improvement in casting of car body parts will now make it possible to make a $25,000 car in about 2 years.
I can remember when the head of GM said that once batteries get to 500 miles the ICE is dead because that is a full tank of gas. We are here now.
Evs are still only about 1% of the cars produced to there is a tremendous market to grow into.
So it is hard to find anything negative about today's show unless you are a day trader.
I think it is pretty clear what Elon is saying.
1) We want to take battery production in house.
2) We want to do it using our new proprietary battery technology which is ready to go.
3) this obviously does not happen in a heartbeat - we have to build the factories.
3) Meantime we will be buying more, not less, butteries from our vendors because of production ramps.
4) As we build out Berlin and Austin we will include new battery plants.
5) Here is what our new batteries can do: 1,2,3...
All good news.
Ohly idiots think everything is going to change overnight and Elon's tweet makes that clear.
It will be interesting to see how the transition works.
Very fuzzy right now.
Eventually, you go to sleep and TSLA uses your car to transport people around.
UBER and LYFT have an enormous fleet of almost every car on the road right now and the software to do the drive and payment,
TSLA can easily copy the user interface but there are not enough available TSLA cars on the road to supply the demand.
My guess is that TSLA gets to level 5 and gets all the kinks worked out and then they manufacture a zillion cars which they (TSLA) own and operate so they can meet the demand. Then TSLA allows individual users to join the network if they want to.
So the first step is Level 5 and solve the insurance problem (self insurance) and to build more GigaFactories so they can flood the streets with TSLA cars. All doable in the near future if TSLA keeps the pedal to the metal.
NASDAQ official PE estimates for TSLA:
Price/Earnings Ratio
labeL....................... value
2019 ActuaL....... -426.86
2020 Estimates.....721.24
2021 Estimates.......224.9
2022 Estimates......112.15
Forecast P/E Growth Rates
labeL....................... value
Growth 2020......... 159.11
Growth 2021........ 220.06
P/E Ratios 2020.....721.24
P/E Ratios 2021.......224.9
https://www.nasdaq.com/market-activity/stocks/tsla/price-earnings-peg-ratios
I did find a reference to potential SNP inclusion later in the month.
See Richard Chen CA comments at this url:
https://seekingalpha.com/news/3611885-teslaminus-4_3-s-and-p-500-rebalance-skips-automaker
Maybe there is hope.
I agree no RS needed at this time.
However, when strong positive results of the drug happen all the big boys will want on board and anything could happen.
A RS and a merger at that time could very well happen or maybe just merge with a whole lot of RLFTF shares for one share of the large company.
Or, if RLFTF really gets it together they could deliver the drug in huge quantities themselves.
Who knows? I am a long term holder until it is either a big winner or big loser.
WTF is that all about?
You said there were 5 slots.
I simply asked you for a link to where you got the info so I can be informed.
You replied "Can you provide a link that there were not?"
Makes no sense.
Do you actually have a information source for the statement?